De-escalation of elective radiotherapy guided by FDG-PET lowers modeled late swallowing-related toxicity in head and neck cancer

Read full text Summarise with VIRAT
Authors: Florian Stritzke, Katharina Dvornikovich, Hin Lau, Thomas Tessonnier, Philipp Schröter, David Neugebauer, Nils Netzer, Lukas Bauer, Rubens Thölken, Erik Winter, Semi Harrabi, Andrea Mairani
+3 more Uwe Haberkorn, Jürgen Debus, Thomas Held
Cited by: 0
References: 34

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Purpose Whether FDG-PET–guided de-escalation of elective target volumes in radiotherapy of the head and neck reduces late toxicity remains uncertain. Therefore, we compared predicted toxicity of two de-escalation strategies—reduced elective nodal irradiation (RNI) and involved node irradiation (INI)—with standard elective nodal irradiation (ENI). Materials and Methods In a within-patient plan comparison (n = 26), we generated RNI and INI plans using the same FDG-PET informed high-/intermediate-risk targets as ENI. RNI limited elective volumes to within 2 cm cranio-caudal from gross disease; INI omitted elective treatment. Proton plans were created in representative oropharyngeal cases. Co-primary outcomes were six-month normal-tissue complication probabilities (NTCPs) for dysphagia, feeding-tube dependence, and xerostomia. Results Median total planning target volume decreased from 540 cm 3 (ENI) to 418 cm 3 (RNI) and 173 cm 3 (INI). RNI and INI reduced modeled dysphagia risk by 5.9 percentage points (pp) (95% CI 2.3 to 9.6 pp; p adj = 0.005) and 11.0 pp (6.9 to 15.2 pp; p adj < 0.001), feeding-tube dependence by 2.8 pp (1.2 to 4.5 pp; p adj = 0.005) and 4.2 pp (2.5 to 6.0 pp; p adj < 0.001), and xerostomia by 2.8 pp (0.0 to 5.7 pp; p adj = 0.054) and 8.8 pp (5.5 to 12.2 pp; p adj < 0.001), respectively. Predicted benefits were greatest in hypopharyngeal and laryngeal cancers. In selected cases, de-escalated proton therapy further reduced organ-at-risk dose. Conclusions FDG-PET–guided volumetric de-escalation was associated with lower modeled late swallowing-related toxicity. These findings support the rationale for ongoing and future trials investigating volumetric de-escalation strategies.

Fields of Study & Subjects

Advanced Radiotherapy Techniques Head and Neck Cancer Studies Radiation Therapy and Dosimetry

Publication details

Journal / source
Clinical and Translational Radiation Oncology
Volume
59
Pages
101156–101156
Publication date
2 April 2026
Language
EN